Works Cited

1. Federation of State Medical Boards. Guidelines for the Chronic Use of Opioid Analgesics. Washington, DC: Federation of State Medical Boards; 2017.

2. Katz NP, Birnbaum H, Brennan MJ. Prescription opioid abuse: challenges and opportunities for payers. Am J Manag Care. 2013;19:295-302.

3. U.S. Food and Drug Administration. Medication Guides: Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS). Available at Last accessed October 20, 2021.

4. American Chronic Pain Association and Stanford Division of Pain Medicine. ACPA-Stanford Resource Guide to Chronic Pain Management: An Integrated Guide to Comprehensive Pain Therapies. Available at Last accessed October 20, 2021.

5. Tanzi MG. Screening pain prescriptions for safe use with VIGIL. Pharmacy Today. 2015;21(9):68.

6. Crespi-Lofton J. VIGIL: answer the question, "Is it legitimate?" Pharmacy Today. 2006;12(1):1.

7. Utah Department of Health. Utah Clinical Guidelines on Prescribing Opioids for Treatment of Pain. Salt Lake City, UT: Utah Department of Health; 2009.

8. Passik SD, Kirsh KL, Whitcomb L, et al. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther. 2004;26:552-561.

9. Bureau of Substance Abuse Services, Massachusetts Department of Public Health. SBIRT: A Step-By-Step Guide for Screening and Intervening for Unhealthy Alcohol and Other Drug Use. Available at Last accessed October 20, 2021.

10. Atluri SL, Akbik H, Sudarshan G. Prevention of opioid abuse in chronic non-cancer pain: an algorithmic, evidence-based approach. Pain Physician. 2012;15:ES177-ES189.

11. Mahajan G. Role of urine drug testing in the current opioid epidemic. Anesth Analg. 2017;125(6):2094-2104.

12. Meier B. Increase in Urine Testing Raises Ethical Questions. Available at Last accessed October 21, 2021.

13. Sekhon R, Aminjavahery N, Davis CN Jr, et al. Compliance with opioid treatment guidelines for chronic noncancer pain (CNCP) in primary care at a Veterans Affairs Medical Center (VAMC). Pain Med. 2013;14(10):1548-1556.

14. Baxter J. Minimizing the Misuse of Prescription Opioids in Patients with Chronic Nonmalignant Pain. Available at Last accessed October 21, 2020.

15. American Medical Association. Promote Safe Storage and Disposal of Opioids and All Medications. Available at Last accessed October 21, 2021.

16. Office of National Drug Control Policy. Proper Disposal of Prescription Drugs. Available at Last accessed October 21, 2021.

17. Walwyn
WM, Miotto KA, Evans CJ. Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions. Drug Alcohol Depend. 2010;108:156-165.

18. Bieber CM, Fernandez K, Borsook D, et al. Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: a pilot case-control study. Exp Clin Psychopharmacol. 2008;16:429-434.

19. Kaye AD, Jones MR1, Kaye AM, et al. Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse (part 2). Pain Physician. 2017;20(2S):S111-S133.

20. Oliver J, Coggins C, Compton P, et al. American Society for Pain Management Nursing position statement: pain management in patients with substance use disorders. Pain Management Nursing. 2012;13:169-183.

21. McPherson ML. Opioids: fears, myths, and misconceptions. Pain View. 2011;7:16-18.

22. Aggarwal SK. Cannabinergic pain medicine: a concise clinical primer and survey of randomized-controlled trial results. Clin J Pain. 2013;29:162-171.

23. Marijuana Policy Project. Medical Marijuana. Available at Last accessed October 21, 2020.

24. Lynch ME, Ware MA. Cannabinoids for the treatment of chronic non-cancer pain: an updated systematic review of randomized controlled trials. J Neuroimmune Pharmacol. 2015;10:293-301.

25. Lynch ME, Clark AJ. Cannabis reduces opioid dose in the treatment of chronic non-cancer pain. J Pain Symptom Manage. 2003;25:496-498.

26. Bushlin I, Rozenfeld R, Devi LA. Cannabinoid-opioid interactions during neuropathic pain and analgesia. Curr Opin Pharmacol. 2010;10:80-86.

27. U.S. Food and Drug Administration. Where and How to Dispose of Unused Medicines. Available at Last accessed October 21, 2021.

28. California Board of Pharmacy. Don't Flush Your Medicines Down the Toilet! Available at Last accessed October 21, 2021.

29. Opioid Analgesics REMS Program Companies. Patient Counseling Guide: What You Need to Know About Opioid Pain Medicines. Available at Last accessed October 21, 2021.

Evidence-Based Practice Recommendations Citations

1. Manchikanti L, Kaye AM, Knezevic NN, et al. Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) guidelines. Pain Physician. 2017;20:S3-S92. Available at Last accessed October 27, 2021.

Copyright © 2021 NetCE, PO Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.